Dr. Sasrutha Wickramasinghe, M.D., PH.D.,
What this data tells you about Dr. Wickramasinghe
Dr. Sasrutha Wickramasinghe is an interventional cardiology in Houston, TX, with 17 years in practice. Based on federal Medicare data, Dr. Wickramasinghe performed 3,977 Medicare services across 2,608 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wickramasinghe received a total of $31,491 from 46 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wickramasinghe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 965 | $86 | $236 |
| Hospital follow-up visit, moderate complexity | 838 | $60 | $158 |
| Regadenoson injection (Lexiscan) for heart stress test | 308 | $44 | $119 |
| Initial hospital admission, moderate complexity | 257 | $93 | $301 |
| Echocardiogram, transthoracic | 211 | $125 | $608 |
| New patient office visit (45-59 min) | 181 | $110 | $363 |
| Hospital follow-up visit, high complexity | 177 | $90 | $226 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 152 | $53 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 150 | $47 | $228 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 149 | $327 | $1,136 |
| Ultrasound of both sides of head and neck blood flow | 72 | $130 | $569 |
| Office visit, established patient, complex (40-54 min) | 67 | $129 | $316 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 65 | $9 | $118 |
| Initial hospital admission, high complexity | 62 | $129 | $441 |
| Cardiac catheterization | 58 | $180 | $708 |
| Office visit, established patient (20-29 min) | 53 | $56 | $159 |
| Ultrasound of heart, follow-up | 47 | $17 | $67 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 40 | $26 | $84 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 37 | $19 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $10 | $37 |
| New patient office visit (30-44 min) | 25 | $59 | $238 |
| Coronary stent placement | 21 | $431 | $1,353 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 13 | $20 | $59 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wickramasinghe is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), and high industry engagement (low-engagement, top 15%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wickramasinghe experienced with office visit, established patient (30-39 min)?
Does Dr. Wickramasinghe receive payments from pharmaceutical companies?
How do Dr. Wickramasinghe's costs compare to other interventional cardiologys in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology